Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:35 PM
Ignite Modification Date:
2025-12-24 @ 7:35 PM
NCT ID:
NCT06461403
Eligibility Criteria:
Inclusion Criteria:
* Age 18-85
* Physician diagnosis of COPD or asthma
* Has been prescribed or is being prescribed one of the inhalers listed below (DPI inhaler product, Active pharmaceutical ingredient):
1. Serevent®Diskus®(GSK), Salmeterol
2. Incruse Ellipta (GSK), Umeclidinium
3. Spiriva Handihaler (BIP),Tiotropium
4. Tudorza Pressair (AstraZeneca), Aclidinium
* Inexperienced with inhaler trainer device (defined by never having had inhaler training using an auxiliary tool besides an actual inhaler and spacer)
Exclusion Criteria:
* Physician declines to provide assent
* Patient unable to provide consent (e.g., history of cognitive impairment, unable to understand English) or declines to provide consent
* Does not meet inclusion criteria
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT06461403
Study Brief:
Protocol Section:
NCT06461403